Upstream Bio, Inc.

UPB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
Assets
Cash & Equivalents$326$26$17
Short-Term Investments$145$84$0
Receivables$1$0$0
Inventory$0$0$0
Other Curr. Assets$8$7$1
Total Curr. Assets$479$117$18
Property Plant & Equip (Net)$2$0$0
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$0$0$0
Total NC Assets$3$0$0
Other Assets$0$0$0
Total Assets$482$117$18
Liabilities
Payables$4$2$1
Short-Term Debt$1$0$0
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.$6$4$4
Total Curr. Liab.$11$7$5
LT Debt$1$0$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$234$120
Total NC Liab.$1$234$120
Other Liabilities$0$0$0
Cap. Leases$2$0$0
Total Liabilities$12$240$125
Equity
Pref Stock$0$0$0
Common Stock$0$0$0
Retained Earnings-$191-$128-$107
AOCI-$0$0$0
Other Equity$661$5$1
Total Equity$470-$123-$106
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$482$117$18
Net Debt-$324-$26-$17
Upstream Bio, Inc. (UPB) Financial Statements & Key Stats | AlphaPilot